AMA Press Releases published a current U.S. medical or healthcare update on October 23, 2026. The story is receiving priority because the agent rated it as a timely, high-impact topic in public health and disease prevention. This article summarizes the verified source material and separates confirmed facts from issues that still need to be watched.
What happened?
The AMA has declared drug shortages to be an urgent public health crisis. Stay informed and access resources to address the impacts on practice.
Key facts from the source
- A 2026 study by the AMA, published in JAMA Network Open, investigated the outcomes associated with drug shortages among primary care physicians (PCPs) and patients, including pervasiveness, treatment changes and outcomes, and administrative burdens.
- The AMA has declared drug shortages to be an urgent public health crisis and a national security threat and is actively working to limit the impact on clinical care.
- Drug shortages impact physicians and patients Drug shortages, defined as a period of time in which demand exceeds supply, pose a significant risk to patient care.
- Current drug shortage database from ASHPThe ASHP drug shortages database is based on reports from healthcare practitioners or patients/caregivers, which is then verified with manufacturers by the University of Utah Drug Information Service to confirm the shortage status for inclusion in its list.
- The ASHP drug shortages database is based on reports from healthcare practitioners or patients/caregivers, which is then verified with manufacturers by the University of Utah Drug Information Service to confirm the shortage status for inclusion in its list.
Why this matters in U.S. healthcare
Public-health alerts can quickly affect prevention, testing, vaccination, infection control, and communication with patients. Fast-moving outbreaks or safety warnings deserve close attention because recommendations may change as new data emerge.
Who may be affected?
Patients, clinicians, public-health departments, pharmacies, laboratories, schools, employers, or healthcare facilities may be affected depending on the event.
What to watch next
- Monitor CDC and state/local health-department updates.
- Watch for case-count, geographic, or exposure updates.
- Check whether testing, vaccination, prevention, or treatment guidance changes.
- Use the latest official guidance for patient-facing decisions.
Key takeaway
This is a developing medical-news item selected for recency, U.S. relevance, potential impact, source quality, and independent coverage where available. The original source remains the authority for exact clinical, regulatory, safety, coverage, or policy details.
Frequently asked questions
Is this article medical advice?
No. It is a news summary based on cited public sources and is not a substitute for clinical guidance or patient-specific medical advice.
How current is this story?
The agent prioritizes articles published within its configured hot-news window and rejects older stories from automatic publication.
How is a topic selected?
Stories are ranked using freshness, U.S. relevance, potential healthcare impact, source authority, and corroboration across separate sources.
Sources
Primary source: Drug shortages: Causes, consequences and mitigation efforts — AMA Press Releases.